| Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue | Frank Vinluan | 09/09/20 | National |
| Roche Spinout Nimble Therapeutics Bags $10M to Find New Peptide Drugs | Jeff Bauter Engel | 04/30/19 | Wisconsin |
| Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More | Alex Lash | 06/30/17 | National |
| Bio Roundup: ASCO Digested, Juliet Unveiled, PTC Slated & More | Alex Lash | 06/09/17 | National |
| Bicycle Therapeutics Maps Course to Clinic Backed by $52M Investment | Frank Vinluan | 06/01/17 | Boston |
| Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M | Ben Fidler | 02/22/17 | New York |
| East Coast Biotech Roundup: Intellia, What’s Hot, Cydan, Fog & More | Ben Fidler | 04/14/16 | Boston |
| With Latest Startup, Harvard’s Verdine Again Aims at Elusive Targets | Ben Fidler | 04/13/16 | Boston |
| Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles | Ben Fidler | 03/04/15 | Boston |
| East Coast Biotech Roundup: Genzyme, 21st Century Cures, Acorda, & More | Ben Fidler | 02/13/15 | Boston |
| East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More | Ben Fidler | 10/31/14 | Boston |
| Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug | Ben Fidler | 10/29/14 | Boston |
| Aileron Therapeutics Secures $33,000,000 Series E Funding | VentureDeal | 10/29/14 | Boston |
| East Coast Biotech Roundup: Moderna, Aileron, Seres, & More | Ben Fidler | 11/22/13 | Boston |
| Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug | Ben Fidler | 11/18/13 | Boston |
| Aileron Therapeutics Garners $30,000,000 Series E Funding Round | VentureDeal | 11/18/13 | Boston |
| East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More | Ben Fidler | 09/06/13 | Boston |
| Aileron Goes After Cancer’s Hard Target, P53, With Peptide Drug | Ben Fidler | 09/03/13 | Boston |
| Hutch’s “Project Violet” Taps Crowd, Seeks $20M for Drug Discovery | Luke Timmerman | 08/15/13 | Seattle |
| Ensemble Reels in Novartis to Develop Oral, Mid-Sized Inflammation Drugs | Ben Fidler | 08/06/13 | Boston |
| Ensemble Adds to Cast of Partners With Alexion Deal | Ben Fidler | 07/18/13 | Boston |
| Harvard Professor Steps Down to Pilot Warp Drive Bio | Ben Fidler | 07/02/13 | Boston |
| East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More | Ben Fidler | 05/10/13 | Boston |
| Aileron Secures Funding for First Stapled Peptide Clinical Trial | Catherine Arnst | 01/14/13 | Boston |
| Aileron Therapeutics Garners $12,000,000 Series D Financing | VentureDeal | 01/14/13 | Boston |
| Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News | Erin Kutz | 11/18/11 | Boston |
| Aileron CEO Hails Expanded Roche Deal as a Validation of Stapled-Peptide Drug Technology | Arlene Weintraub | 11/17/11 | Boston |
| Atlas and Monsanto the Latest VC and Big Co. Getting Close | Ryan McBride | 04/14/11 | Boston |
| Bill Gates Backs Nimbus, Betting on Computer-Based Drug Discovery | Ryan McBride | 03/10/11 | Boston |
| Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News | Erin Kutz | 12/03/10 | Boston |
